STAT Plus: Patients, backed by ‘dark money’ group, get ready to debate Duchenne drug prices. It will not be boring
Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping. A Duchenne meeting may prove the exception to the rule.
No hay comentarios:
Publicar un comentario